|
KarX-EC Clinical Trials
3 actively recruiting trials across 3 locations
Also known as: BMS-986519, Xanomeline enteric capsules, BMS-986519
Pipeline
Phase 3: 3
Top Sponsors
- Bristol-Myers Squibb3
Indications
- Alzheimer's Disease3
- Agitation1
- Alzheimer Disease1
Chandler, Arizona1 trial
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Local Institution - 2609
Phase 3
Fullerton, California1 trial
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Fullerton Neurology and Headache Center
Phase 3
Long Beach, California1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.